Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review
BackgroundStudies have reported that patient-related factors significantly impact the risk of Chemotherapy-Induced Nausea and Vomiting (CINV). The objective of this study was to analyze those risk factors of CINV through a systematic literature review.MethodsWe searched MEDLINE to identify articles...
Main Authors: | Abu Saleh Mohammad Mosa, A. Mosharraf Hossain, Beau James Lavoie, Illhoi Yoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00329/full |
Similar Items
-
Chemotherapy induced nausea and vomiting may cause anxiety and depression in the family caregivers of patients with cancer
by: Xiaozhen Luo, et al.
Published: (2023-09-01) -
Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
by: Yi Cheng, et al.
Published: (2022-07-01) -
Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
by: Rashad N, et al.
Published: (2017-03-01) -
Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects
by: Lorenzo Pradelli, et al.
Published: (2007-06-01) -
Olanzapine enhances the effect of conventional drugs in chemotherapy induced nausea and vomiting: A randomized clinical trial
by: Atefe Khani, et al.
Published: (2022-02-01)